This Pediatric Lecture Series will discuss important pediatric topics that may lead to the improvement of child health from an individual, health care system and/or societal level.
Presenter
Paul E. Palumbo, MD
Director, International Pediatric HIV Program
Dartmouth-Hitchcock and Professor of Medicine and Pediatrics
Geisel School of Medicine
Learning Outcome
At the conclusion of this presentation, (at least 75% of) participants will be able to describe current and anticipated COVID epidemiology that guide patient care in the clinical setting.
Disclosure
The following, speaker, has reported the following financial relationships with ineligible companies. All of the relevant financial relationships listed for these individuals have been mitigated.
Paul Palumbo, MD - Jannsen (J&J) and Gilead: DSMB Member for each.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this activity report NO financial relationship(s)* with any ineligible company(ies)**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Material
- Jingyi Xiao, P Jacob Bueno de Mesquita, Nancy H L Leung, Oluwasanmi Adenaiye, Sheldon Tai, Matthew B Frieman, Filbert Hong, Daniel K W Chu, Dennis K M Ip, Benjamin J Cowling, Donald K Milton, Prometheus-UMD Consortium, Viral RNA and Infectious Influenza Virus on Mobile Phones of Patients With Influenza in Hong Kong and the United States, The Journal of Infectious Diseases, Volume 224, Issue 10, 15 November 2021, Pages 1730–1734, https://doi.org/10.1093/infdis/jiab464
- Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion Veronique Nussenblatt,1,a Allison E. Roder,2,a Sanchita Das,3 Emmie de Wit,4, Jung-Ho Youn,3 Stephanie Banakis2 , Alexandra Mushegian,2 Christopher Mederos,2 Wei Wang,2 Matthew Chung,2 Lizzette Pérez-Pérez,4 Tara Palmore,5 Jennifer N. Brudno,6 James N. Kochenderfer,6 and Elodie Ghedin, The Journal of Infectious Diseases® 2022;225:1118–23 Published by Oxford University Press for the Infectious Diseases Society of America 2021. This work is written by (a) US Government employee(s) and is in the public domain in the US. https://doi.org/10.1093/infdis/jiab622
- Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies, Benood et al; J Infection 2022
- BNT162b2 2-Dose Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection in Children and Adolescents, Fleming-Dutra/CDC et al, JAMA - May 2022
- Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2; Goldberg et al; NEJM 5/25/22
- Breakthrough Infection compared with Control Group, Al-Aly et al; Nature Medicine 2022
- Nonessential Research in the New Normal: The Impact of COVID-19, Am J Trop Med Hyg. 2020 Jun; 102(6): 1164–1165. Published online 2020 Apr 24. doi: 10.4269/ajtmh.20-0325. PMCID: PMC7253117, PMID: 32333545 , Stephanie K. Yanow1,2,* and Michael F. Good2,3,*
- Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis, Mejbah Uddin Bhuiyan,a,1,? Eunice Stiboy,b,1 Md. Zakiul Hassan,c Mei Chan,d Md. Saiful Islam,c,e Najmul Haider,f Adam Jaffe,d,g and Nusrat Homairad,g,Vaccine. 2021 Jan 22; 39(4): 667–677. Published online 2020 Dec 5. doi: 10.1016/j.vaccine.2020.11.078, PMCID: PMC7833125
PMID: 33342635 - COVID-19 in Children: An Ample Review, Ioana M Ciuca1, Risk Manag Healthc Policy. 2020; 13: 661–669. Published online 2020 Jun 25. doi: 10.2147/RMHP.S257180, PMCID: PMC7334563, PMID: 32636686
